| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |